Modular Medical, Inc. (MODD) financial statements (2020 and earlier)

Company profile

Business Address 800 WEST VALLEY PARKWAY
ESCONDIDO, CA 92025
State of Incorp. NV
Fiscal Year End March 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
TTM
3/31/2019
3/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,7186,5544,2971,372   
Cash and cash equivalents3,7186,5544,2971,372   
Prepaid expense     3 
Other current assets501617    
Other undisclosed current assets4      
Total current assets:3,7736,5694,3131,372 3 
Noncurrent Assets
Property, plant and equipment1107613    
Intangible assets, net (including goodwill) 00   
Intangible assets, net (excluding goodwill) 00    
Other undisclosed noncurrent assets 88    
Total noncurrent assets:1108421    
TOTAL ASSETS:3,8836,6534,3341,372 3 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2541791574634531
Accounts payable254     2
Accrued liabilities   74   
Interest and dividends payable    634530
Other undisclosed accounts payable and accrued liabilities 17915    
Due to related parties  1 131120100
Total current liabilities:2541791574194165132
Noncurrent Liabilities
Other undisclosed liabilities20      
Total liabilities:2751791574194165132
Stockholders' equity
Stockholders' equity attributable to parent, including:3,6086,4744,3191,298(194)(163)(132)
Common stock1818164111
Common stock, share subscribed but unissued, subscriptions receivable 20     
Additional paid in capital10,2429,6855,012306838383
Accumulated deficit(6,651)(3,248)(709)(384)(278)(247) 
Other undisclosed stockholders' equity attributable to parent   1,372  (216)
Total stockholders' equity:3,6086,4744,3191,298(194)(163)(132)
TOTAL LIABILITIES AND EQUITY:3,8836,6534,3341,372 3 

Income statement (P&L) ($ in thousands)

12/31/2019
TTM
3/31/2019
3/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Operating expenses(4,570)(2,577)(666)(91)(13)(16)(11)
Other operating expense, net      (12)
Other undisclosed operating income      12
Operating loss:(4,570)(2,577)(666)(91)(13)(16)(11)
Nonoperating income (expense)44   (18)(15) 
Investment income, nonoperating44      
Other nonoperating expense    (18)(15) 
Interest and debt expense   (16)(18)(15)(12)
Loss from continuing operations before equity method investments, income taxes:(4,525)(2,577)(666)(107)(49)(46)(23)
Other undisclosed income from continuing operations before income taxes 399 1815 
Loss from continuing operations before income taxes:(4,525)(2,538)(658)(107)(31)(31)(23)
Income tax expense (2)(2)  (79)(63)
Net loss:(4,525)(2,539)(659)(107)(31)(110)(86)
Other undisclosed net income attributable to parent     7963
Net loss available to common stockholders, diluted:(4,525)(2,539)(659)(107)(31)(31)(23)

Comprehensive Income ($ in thousands)

12/31/2019
TTM
3/31/2019
3/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net loss:(4,525)(2,539)(659)(107)(31)(110)(86)
Comprehensive loss, net of tax, attributable to parent:(4,525)(2,539)(659)(107)(31)(110)(86)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: